Healthcare
Spotlight on 2 FTSE Pharma Stocks: Astrazeneca PLC and Indivior PLC
May 25, 2021 01:11 PM BST| By Suhita PoddarSummary A recent GlobalData survey highlighted a majority of US, and UK healthcare professionals believed the UK is an attractive destination for research and manufacturing in the sector post Brexit. Vaccine maker AstraZeneca’s share drop.....
Vaccination Visibly Helps in Abating Existential Threat to Life
May 23, 2021 12:16 AM BST| By AbhijeetSumamry As per PHE, the Covid-19 inoculation programme alone has helped in preventing more than 11,000 deaths in England Various medical experts initially believed that there could be severe issues with the people who have received the Covid-19.....
3 Global Pharma Stocks in Focus as UK Enters Talks to Waive Vaccine Patents
May 21, 2021 10:23 AM BST| By Suhita PoddarSummary The UK and EU are in talks to waive vaccine patents after the US supported the initiative. India and South Africa have long been asking for waiving patents under the World Trade Organisation’s Trade-Related Aspects of Intellectual.....
Oxford Biomedica Shares Surge as Revenue Expectation from AstraZeneca Doubles
May 18, 2021 03:59 PM BST| By AbhijeetSummary Oxford Biomedica on Tuesday almost doubled its revenue expectation from AstraZeneca Plc, as it bagged more batches vaccine order. Biomedica raised its revenue guidance from over £50 million to over £100 million from AstraZen.....
GSK-Sanofi Jab Reports Positive Results in Phase 2 Trials
May 18, 2021 11:37 AM BST| By Suhita PoddarSummary After an initial setback, the companies reported success for their Covid-19 vaccine candidate. The candidate’s global phase III study is likely to begin in the next few weeks. The vaccine could get approval by the end of th.....
3 FTSE AIM Pharma Stocks That Have Given Returns of Over 100% In a Year
May 13, 2021 02:01 PM BST| By Suhita PoddarPharmaceuticals and biotechnology stocks have gained attention in recent times, especially vaccine related stocks, due to their contribution in the fight against the pandemic. But, aside from pharma giants, the rest of the pharmaceutical and biotec.....
Four Small-Cap Healthcare Stocks That Have Given Over 50 Per Cent Return in A Year
May 12, 2021 12:52 PM BST| By AbhijeetSummary Over the last year, the biotechnology and pharmaceuticals index has been the second-worst performer in the FTSE350 Index. Healthcare stocks are a risky investment as these biotechnology firms work on breakthrough scientific research, wh.....
A Glance at 5 Healthcare Penny Stocks
May 08, 2021 12:30 AM BST| By Suhita PoddarSummary Second phase of coronavirus and new mutations seek advanced healthcare supplies. Vaccine rollout has not affected the demand for test kits and scanning machines. Manufacturers and distributors of diagnostic solutions are gaining invest.....
Vaccine Stocks in News: Pfizer’s Profits Rise, AstraZeneca Faces Opposition to CEO’s Bonus Hike
May 05, 2021 12:42 PM BST| By Suhita PoddarSummary Pfizer predicts US$ 26 billion from sales of Covid-19 vaccine in 2021 Proposed bonus hike for AstraZeneca’s CEO to be opposed by investors Over 1.18 billion Covid-19 vaccine doses have been administered across the globe as of.....
What are the foundation stones laid by Tristel to resume revenue and profit growth from FY22?
April 26, 2021 04:08 PM BST| By Team Kalkine MediaSummary TSTL expects FY21 global sales to remain around £31 million for the year ending on 30 June 2021. The surface disinfectant product sales in the UK had witnessed a 47% growth to £2.3 million during Q3 FY21. TSTL had anticipat.....
How These 2 Healthcare Stocks Performed Amid Pandemic Challenge
April 16, 2021 01:13 PM BST| By Suhita PoddarSource: BlurryMe, Shutterstock Summary: UK's leading cell and gene therapy firm Oxford Biomedica reported a 37 per cent increase in its revenue to £87.7 million for FY20. PureTech’s operating losses shrunk from $135.39 million in 201...
Crypto Kings: Extraordinary Tale of Coinbase Founders Brian Armstrong, Fred Ehrsam
April 15, 2021 10:18 AM BST| By Team Kalkine MediaSource: DSkorynko, Shutterstock Summary Although Coinbase made a smashing debuted on NASDAQ, opening 4% higher than the reference price, the Company had humble beginnings. Co-founders Fred Ehrsam and Brian Armstrong met on Reddit and built the...
Covid-19 Vaccine Makers in News: J&J, AstraZeneca and Pfizer
April 14, 2021 10:45 AM BST| By Suhita PoddarSource: insta_photos, Shutterstock Summary J&J delays the distribution of its Covid-19 vaccine to Europe. US may not use the AstraZeneca vaccine, says the chief pandemic adviser to the White House. Pfizer is likely to meet its US supply t...
AstraZeneca’s Farxiga Fails to Yield Statistical Significance for Covid-19 Treatment
April 12, 2021 11:27 AM BST| By Suhita Poddarand concerns of using SGLT2 inhibitors to treat Covid-19 patients admitted to hospital. Things are not at all smooth for the pharma major AstraZeneca Plc (LON: AZN). After getting mired in various controversies related to its Covid-19 vaccine (....
EMA Supports Astrazeneca Jabs Despite Links with Rare Blood Clots
April 07, 2021 04:55 PM BST| By AbhijeetSource: LookerStudio, Shutterstock Summary The European Medicines Agency has said that the benefits of using AstraZeneca vaccine outweigh the potential risks it had highlighted before. The MHRA is also scheduled to come up with an up...
10 Cheap Healthcare Stocks to Ponder Over This Easter
April 05, 2021 12:37 AM BST| By AbhijeetSource: Guschenkova, Shutterstock Summary On a YTD scale, healthcare stocks have multiplied the investors’ wealth by almost 2.5 times. Healthcare sector has a lot of ground to cover, and businesses can access a huge door of growth opport...
Moderna vaccine to be rolled out in April as UK aims to vaccinate all adults by July
March 29, 2021 06:37 PM BST| By AbhijeetSource: insta_photos, Shutterstock Summary The UK authorities said that first jabs of Moderna vaccine would be rolled out in April. The Boris Johnson government had said that it was committed to its plans to vaccinate the entire adult populati...
Astrazeneca Vaccine Less Effective Than Earlier Touted, Claims Latest Trial Results
March 25, 2021 10:47 AM GMT| By AbhijeetSource: PhotobyTawat, Shutterstock Summary The Oxford-AstraZeneca vaccine is 76 per cent effective against the coronavirus infection. The earlier US clinical trial results had put the value a tad higher at 79 per cent. Despite the lower rate,...
AstraZeneca Shares Making ‘Inverse Head And Shoulders’ Pattern Amid Vaccine Chaos
March 19, 2021 02:50 PM GMT| By AbhijeetSource: PhotobyTawat, Shutterstock Summary Shares of AstraZeneca have experienced a turbulent trading session of late. The stock was trading at GBX 7,133, up 0.07 per cent on 19 March. This year so far, the stock has largely fallen extending...
Vaccine Stocks in Focus as AstraZeneca Awaits EU Verdict on Its Jabs
March 16, 2021 04:00 PM GMT| By Suhita PoddarSource: Aedka Studio, Shutterstock Summary AstraZeneca has recently faced suspensions from several countries and now is awaiting the EU medical watchdog’s official verdict. The company’s shares are still in the green as the World H...